title: Oral isotretinoin and pregnancy prevention programmes.
authors: D
authors: D
authors: Thiboutot
authors: H
authors: H
authors: Gollnick
authors: V
authors: V
authors: Bettoli
authors: B
authors: B
authors: Dréno
authors: S
authors: S
authors: Kang
authors: J J
authors: JJ
authors: Leyden
authors: A
authors: A
authors: Shalita
authors: V
authors: V
authors: Torres
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*; D011247:Pregnancy; D013723:Teratogens
chemical_list: D003879:Dermatologic Agents; D013723:Teratogens; D015474:Isotretinoin